Fig. 4: In vitro biological functions of cells delivered using S-cryoMNs.
From: In situ-formed cryomicroneedles for intradermal cell delivery
A Schematic of the application of S-cryoMNs for allogeneic and autologous cell therapies. The secretion effects of hMSCs delivered using S-cryoMNs on promoting (B) in vitro wound closure and (C) vascularization. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001; ns no significant difference. n = 3.
